MRI and biopsy quality
Ask whether the hospital reviews the MRI and biopsy together and can repeat pathology when the grade or extent is uncertain.
Uro-oncology in India
A guide to comparing uro-oncology hospitals for PSA assessment, prostate MRI, biopsy interpretation, risk-based treatment, and urinary and sexual recovery support.
What makes a prostate cancer hospital suitable?
Choose a team that can distinguish low-risk disease from aggressive or metastatic cancer, explain surveillance, surgery, radiation, and hormone options, and address urinary, bowel, sexual, and fertility concerns before treatment.
Share your treatment records
A report-led review helps the care team compare procedure fit, hospital capability, city, timing, and travel needs before an enquiry is sent.
Official email: support@virellohealth.com
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Shortlist decision
Ask whether the hospital reviews the MRI and biopsy together and can repeat pathology when the grade or extent is uncertain.
A good consultation should explain why surveillance, surgery, radiation, or medicine is appropriate for the patient’s risk group.
If robotic prostatectomy is offered, discuss suitability, surgeon experience, lymph nodes, continence expectations, and alternatives.
Ask about planning, rectal and bladder protection, treatment duration, and how hormone therapy fits the plan.
For spread beyond the prostate, compare medical oncology, imaging, bone health, pain, and long-term medicine monitoring.
Confirm that urinary, sexual, fertility, pelvic-floor, and psychosocial concerns can be discussed confidentially.
Hospitals patients often compare
The examples below are not a fixed ranking. They show how families can discuss hospital types, city routes, and department strengths before a report-led shortlist is prepared.
New Delhi
Cancer-focused route with urology, medical oncology, radiation, imaging, and pathology review.
It may suit patients looking for an oncology-led setting where risk and stage can be assessed across several departments.
Ask for a written comparison of surveillance, surgery, radiation, and medicine options before committing.
Evidence check
Campus reviewed: Rajiv Gandhi Cancer Institute and Research Centre, New Delhi. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Gurugram
Multispecialty uro-oncology pathway with robotic surgery, imaging, radiation, and medical care discussions.
A multispecialty campus can help when prostate cancer care intersects with kidney, cardiac, or other conditions.
Confirm the named surgeon, robotic programme details, hospital campus, and post-operative continence support.
Evidence check
Campus reviewed: Medanta - The Medicity, Gurugram. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Chennai
Tertiary oncology setting with urology, radiation, systemic treatment, imaging, and international patient coordination.
Chennai provides a broad private-care route for patients comparing surgery and radiation pathways.
Ask whether prostate MRI and biopsy review can be completed before the first treatment consultation.
Evidence check
Campus reviewed: Apollo Cancer Centre, Chennai. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Gurugram
Private hospital route for urology, radiation, oncology, imaging, and peri-operative support.
Gurugram may be convenient for planned private treatment and airport access.
Request separate estimates for surgery, pathology, hospital stay, medicines, and continence rehabilitation.
Evidence check
Campus reviewed: Fortis Memorial Research Institute, Gurugram. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Mumbai
Private cancer and urology pathway with surgery, radiation, imaging, and medical oncology.
Mumbai can be considered by patients seeking a large private hospital ecosystem and specialist consultations.
Clarify whether the proposed plan is curative or disease-controlling and what follow-up happens locally.
Evidence check
Campus reviewed: Kokilaben Dhirubhai Ambani Hospital, Mumbai. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Bengaluru
Cancer network with uro-oncology, radiation, imaging, and systemic treatment access.
Bengaluru may work for patients combining specialist treatment with a longer recovery stay.
Verify the branch, named urologist, radiation availability, and expected treatment calendar.
Evidence check
Campus reviewed: HCG Cancer Centre, Bengaluru. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Mumbai
Dedicated cancer institution for oncology-led review and stage-appropriate treatment discussions.
Families may consider it for a cancer-focused evaluation while planning around public hospital capacity.
Confirm registration, current appointment route, report format, and waiting time before travel.
Evidence check
Campus reviewed: Tata Memorial Hospital, Mumbai. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Kochi
Tertiary care option with urology, oncology, imaging, surgery, and recovery support.
Kochi may be useful for selected planned cases where the patient values a structured recovery setting.
Ask whether radiation or long-term medicines can be coordinated after the patient returns home.
Evidence check
Campus reviewed: Aster Medcity, Kochi. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Cancer-specific care pathway
The right hospital should be able to coordinate the tests, pathology review, treatment decisions, and recovery support that match this cancer type and the patient’s current condition.
The aim is to confirm cancer, measure its grade, and understand whether it is confined to the prostate.
The team reviews PSA trend, symptoms, family history, medicines, and examination findings rather than interpreting one PSA value alone.
Multiparametric MRI can help identify suspicious areas, assess local anatomy, and guide biopsy decisions in selected patients.
Biopsy samples are assessed for cancer, Grade Group or Gleason pattern, the number of involved cores, and other relevant features.
Genetic, genomic, bone, CT, or advanced imaging tests may be considered when risk, family history, or spread makes them useful.
Risk grouping helps separate patients who may safely monitor disease from those who need active treatment.
MRI and examination help assess whether the tumor appears confined or extends beyond the prostate or into nearby structures.
PSA, Grade Group, tumor stage, and biopsy burden are combined to describe low, intermediate, high, or very-high risk.
Selected patients may need PSMA PET, CT, bone imaging, or other scans to assess nodes or distant disease.
Age, health, life expectancy, urinary function, sexual function, and personal preference belong in the treatment decision.
The hospital should explain the trade-offs of each route, including what happens if the first plan is not enough.
Selected lower-risk patients may discuss repeat PSA, MRI, examination, and biopsy rather than immediate surgery or radiation.
Radical prostatectomy may be open, laparoscopic, or robotic depending on the patient and team; lymph-node and nerve-sparing decisions should be explained.
External radiation, brachytherapy in selected cases, and androgen-deprivation treatment may be combined according to risk.
Metastatic or recurrent disease may involve hormone medicines, chemotherapy, targeted treatment, radiopharmaceuticals, or symptom care.
Follow-up is both a cancer surveillance plan and a recovery plan for urinary, sexual, bowel, and bone health.
The treating team sets PSA timing and explains what pattern would prompt imaging, treatment adjustment, or closer review.
Continence, pelvic-floor exercises, erectile function, bowel symptoms, and pain should be reviewed openly after treatment.
Patients receiving androgen-deprivation therapy may need discussion of hot flashes, metabolic health, mood, bone density, and cardiovascular risk.
Ask for the final pathology, PSA target or schedule, medication plan, warning signs, and the doctor’s remote follow-up process.
Selection criteria
Does the hospital explain Grade Group, PSA, MRI findings, and spread before recommending treatment?
A procedure should not be selected from PSA alone.
Are urology, radiation, medical oncology, radiology, and pathology available when needed?
Ask who will lead the treatment plan.
If offered, can the surgeon explain suitability, alternatives, recovery, and functional outcomes without guarantees?
Technology should follow clinical fit.
What technique, number of visits, image guidance, and hormone sequence are proposed?
The plan should match the risk group.
Can the center manage bone, urinary, pain, medicine, and palliative needs if disease has spread?
Ask about emergency access.
Are pelvic-floor, sexual health, fertility, counselling, and rehabilitation services available?
These are part of informed consent.
Treatment fit
The same hospital can be strong in several areas, but each patient still needs matching by diagnosis, procedure, risk, and recovery needs.
The best route may be surveillance, surgery, or radiation depending on risk and patient preference.
Ask for a side-by-side explanation of cancer control, urinary effects, sexual effects, bowel effects, recovery, and future options.
A prostatectomy discussion should include catheter care, pelvic-floor work, pathology timing, and the possibility of additional treatment.
Long-term care requires medicine monitoring, imaging, symptom control, and quality-of-life planning.
Ask how hormone, chemotherapy, targeted, or radiopharmaceutical options will be chosen and monitored.
Confirm plans for bone health, pain, urinary obstruction, fatigue, sexual health, and emotional support.
City strategy
Offers oncology institutes and private multispecialty routes for uro-oncology.
Compare New Delhi and Gurugram by team, stay, and airport access.
Provides cancer-focused institutions and private hospitals with urology and radiation options.
Ask for a risk-specific plan and total stay.
A broad tertiary route for surgery, radiation, pathology, and systemic care.
Confirm prostate MRI, biopsy review, and radiation capacity.
Offer private urology and cancer networks for planned treatment.
Verify surgeon credentials and campus-level services.
May suit follow-up or selected planned treatment with a clear care handover.
Complex staging or recurrence may need a major cancer center.
Reports before matching
Reports help the hospital and doctor team understand whether the patient needs a complex metro route, a specialty center, or a stable planned-care option.
Cost and stay planning
MRI review, targeted biopsy, anesthesia, pathology, and molecular or genomic testing may be billed separately.
Ask whether outside pathology can be accepted.
Approach, surgeon, room, pathology, ICU need, catheter care, and pelvic-floor rehabilitation affect cost.
Request a package exclusions list.
Planning, technique, number of sessions, and hormone medicines can change the episode total.
Ask for the treatment duration before booking lodging.
Hormone, chemotherapy, targeted, or supportive medicines can continue after the initial stay.
Request monthly medicine estimates when relevant.
Pelvic-floor therapy, continence supplies, sexual health support, and follow-up visits may add time and cost.
Plan recovery rather than only the operation date.
International patient support
A coordinator can help arrange a confidential consultation and collect the PSA, MRI, and biopsy record set.
A dated calendar can show MRI review, biopsy, surgery or radiation, catheter removal, and follow-up.
Ask about airport transfers, accessible accommodation, and support after catheter or major surgery.
Request pelvic-floor, urinary, bowel, sexual health, and counselling referrals when appropriate.
The discharge plan should include dose, duration, monitoring, and what to do if a medicine is missed.
Confirm how PSA results and recovery questions will be reviewed after the patient returns home.
Safety checks
A recommendation that ignores MRI, biopsy grade, stage, health, and patient preference needs further review.
Robotic surgery is an approach, not a guarantee of continence, erections, or cancer control.
Ask whether pathology, catheter care, hormone therapy, radiation, and rehabilitation are excluded.
The hospital should make space for urinary, sexual, fertility, bowel, and psychological concerns.
Sources and review
Hospital availability, accreditation, authorization, and treatment claims can change. Confirm the current campus details with the hospital before travel or admission.
Clinical pathway reviewed for page planning on 30 July 2026. Risk groups, treatment availability, costs, and hospital services require current medical confirmation.
Questions
Compare risk-based clinical review, urology and oncology teamwork, pathology and imaging, surgery and radiation choices, and support for long-term function.
No. Suitability depends on cancer extent, health, anatomy, surgeon assessment, alternatives, and patient priorities.
Yes, selected lower-risk patients may discuss surveillance with scheduled PSA, imaging, examination, and sometimes repeat biopsy.
They are different treatment routes with different timing, side effects, recovery, and follow-up. A specialist should compare them for the patient’s risk group.
The stay depends on biopsy, surgery, complications, and recovery. Radiation may involve repeated outpatient visits rather than one admission.
Send PSA history, MRI images, biopsy report and slides if available, staging scans, current medicines, and prior treatment summaries.
It can. The expected risk depends on the treatment and patient factors, so ask the team about rehabilitation and realistic recovery timelines.
Virello Health can organize records and hospital enquiries for comparison; the clinical team decides which treatment is appropriate.
Continue planning
Understand surveillance, surgery, radiation, and medicines.
Review cost and stay variables.
Request a uro-oncology review.
Browse the wider cancer hospital list.
Share PSA, MRI, and biopsy records.
Ask for an independent treatment discussion.
Explore other comparison pages.
Plan coordination and travel.
Review a city-based pathway.